Lead party: Strides Pharma Asia Pte Ltd. (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Trinity Pharma (Pty) Ltd. (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: South Africa
Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Equity · Deal amount: US$4.3m · Equity stake: 0.55% · Implied EV: US$7.9m
Lead investor/buyer: Strides Pharma Asia Pte Ltd. · Investors/buyers: Strides Pharma Asia Pte Ltd.
Legal advisers: not identified in the source record.
Source: announced 20 December 2017. Original announcement: strides.com.


